Quasi‑Septal Hypertension: A Comprehensive Patient Guide

Overview

Quasi‑septal hypertension (QSH) is a rare form of secondary hypertension caused by an abnormal pressure gradient across the interatrial septum of the heart. The condition results from a partial or functional obstruction within the atrial septum that impedes the normal flow of blood between the right and left atria, leading to elevated systemic arterial pressure.

QSH is most commonly identified in adults between the ages of 30 and 65, but case reports describe it in younger patients with congenital septal abnormalities. Because the condition is uncommon, exact prevalence data are limited; however, epidemiological surveys suggest that it accounts for less than 0.1 % of all hypertension cases in tertiary cardiac centers worldwide [1][2].

Symptoms

Symptoms of quasi‑septal hypertension arise from both the high blood pressure itself and the hemodynamic effects of the septal obstruction. Not every patient experiences all of them.

• Persistent high blood pressure – readings >140/90 mmHg on at‑least two separate occasions.
• Headaches – throbbing or pressure‑type, often worse in the morning.
• Dizziness or light‑headedness – especially when standing quickly.
• Palpitations – irregular or rapid heartbeat sensation.
• Shortness of breath (dyspnea) – during exertion or, in advanced cases, at rest.
• Fatigue – generalized lack of energy not explained by lifestyle.
• Chest discomfort – mild pressure or tightness; rarely angina‑like pain.
• Swelling of the ankles or lower legs (peripheral edema) – due to fluid retention.
• Nocturia – waking up more than once at night to urinate, a common sign of fluid overload.
• Exercise intolerance – inability to sustain previously easy activities.

Because QSH mimics essential hypertension, many patients first notice only the elevated blood pressure on routine screening.

Causes and Risk Factors

QSH is a **secondary** hypertension disorder; the underlying problem is mechanical rather than purely vascular.

Primary Causes

1. Congenital atrial septal defect (ASD) variants – an incomplete or thickened septum that creates a functional obstruction.
2. Acquired septal fibrosis or calcification – often secondary to prior cardiac surgery, radiation therapy, or chronic inflammatory disease.
3. Infiltrative diseases – sarcoidosis, amyloidosis or eosinophilic myocarditis can thicken the septum.
4. Neoplastic involvement – rare tumors (e.g., atrial myxoma) that partially block the septal opening.

Risk Factors

• History of congenital heart disease or prior cardiac surgery.
• Radiation exposure to the chest (e.g., for lymphoma) >10 years prior.
• Systemic inflammatory disorders (e.g., rheumatoid arthritis, sarcoidosis).
• Age >40 years (fibrotic changes accumulate).
• Male sex – slight predominance in reported series [3].

Diagnosis

Diagnosing QSH requires a systematic approach to rule out more common causes of hypertension and to identify the septal abnormality.

Step‑wise Evaluation

1. Clinical assessment – detailed history, physical exam, and measurement of blood pressure in both arms.
2. Routine laboratory tests – CBC, electrolytes, fasting glucose, lipid profile, renal function, and urine microalbumin to assess end‑organ damage.
3. Echocardiography (transthoracic, TTE) – first‑line imaging. Looks for septal thickness, flow velocities across the interatrial septum, and signs of right‑heart strain.
4. Transesophageal echocardiography (TEE) – provides higher resolution of the septum if TTE is inconclusive.
5. Cardiac MRI (CMR) – Gold standard for tissue characterization (fibrosis, calcification) and precise measurement of pressure gradients.
6. Right‑heart catheterization – Invasive measurement of pressures in the right atrium, left atrium, and pulmonary artery; a >10 mmHg gradient across the septum supports QSH diagnosis.
7. CT angiography – Useful when MRI is contraindicated (e.g., pacemaker